Medeon Biodesign (6499) — Cash Flow Quality Index
Medeon Biodesign (6499) has a Cash Flow Quality Index of 0.90x as of March 2022. Operating cash flow of NT$60.74 Million is below net income of NT$67.17 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Medeon Biodesign (6499) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medeon Biodesign Cash Flow Quality Index (2018–2021)
Historical Cash Flow Quality Index for Medeon Biodesign across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Medeon Biodesign cash conversion from operations.
Annual Cash Flow Quality Index for Medeon Biodesign (2018–2021)
Year-by-year earnings quality comparison for Medeon Biodesign.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.14x | NT$-293.38 Million | NT$2.08 Billion | ▼ -111.2% |
| 2018 | 1.26x | NT$322.05 Million | NT$256.60 Million | — |